Drucker A M, Su J, Mussani F, Siddha S K, Gladman D D, Urowitz M B
Division of Dermatology, University Health Network, Toronto Western Hospital, Toronto, Canada
Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Toronto, Canada.
Lupus. 2016 Apr;25(4):376-81. doi: 10.1177/0961203315610645. Epub 2015 Oct 8.
Cutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and malar rash on SLE disease activity.
Data were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or malar rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).
A total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with malar rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with malar rash, AMS scores at one (8.30 ± 6.80, p < 0.001) and five years (5.23 ± 3.06, p = 0.004) were higher than controls without CLE.
Malar rash may be a marker of more severe systemic disease over time, while DLE has no significant impact on general SLE disease activity.
皮肤型红斑狼疮(CLE)可能对系统性红斑狼疮(SLE)的预后有影响。我们旨在确定盘状红斑狼疮(DLE)和蝶形红斑对SLE疾病活动度的影响。
对多伦多狼疮诊所前瞻性队列研究的数据进行分析。我们将SLE诊断时伴有活动性DLE或蝶形红斑的患者与从未发生过CLE的SLE患者进行比较。在1年和5年时评估结果,包括校正后的平均系统性红斑狼疮疾病活动指数2000(AMS)。
共纳入524例SLE患者(284例无CLE,65例有DLE,175例有蝶形红斑)。无CLE的患者在1年和5年时的平均AMS评分分别为5.96±5.06和4.00±3.52,与DLE组1年(6.93±5.31,p = 0.17)和5年(4.29±2.62,p = 0.63)时的评分无显著差异。有蝶形红斑的患者在1年(8.30±6.80,p < 0.001)和5年(5.23±3.06,p = 0.004)时的AMS评分高于无CLE的对照组。
随着时间推移,蝶形红斑可能是更严重系统性疾病的一个标志,而DLE对SLE总体疾病活动度无显著影响。